Go Premium in Our Biggest Sale Ever

Go Ultimate 75% OFF

SLXN Stock Latest News

Company AnnouncementsSilexion Therapeutics Completes 1-for-24 Reverse Share Split2d ago8K SLXN

The FlySilexion Therapeutics Corp trading halted, news pending3d agoSLXN
Company AnnouncementsSilexion Announces Reverse Share Split to Address Nasdaq Compliance5d ago8K SLXN
The FlySilexion Therapeutics announces 1-for-24 reverse share split5d agoSLXN
The FlySilexion registers to sell 8.81M ordinary shares for holders2w agoSLXN

Silexion Therapeutics Shareholders Approve Major Capital Restructuring

Company AnnouncementsSilexion Therapeutics Shareholders Approve Major Capital Restructuring2w ago8K SLXN

Company AnnouncementsSilexion Therapeutics Begins Global SIL204 Pancreatic Cancer Trial1M ago8K SLXN

The FlySilexion announces first patient dosed in Phase 2/3 trial of SIL2041M agoSLXN

Company AnnouncementsSilexion Therapeutics Announces Warrant Inducement Financing Deal1M ago8K SLXN
Company AnnouncementsSilexion Highlights Positive Translational Data for RNAi Oncology1M ago8K SLXN
The FlySilexion Therapeutics reports preclinical findings for SIL2041M agoSLXN
Company AnnouncementsSilexion Therapeutics Shareholders Reject Capital Structure Changes1M ago8K SLXN

Silexion Therapeutics Receives Nasdaq Bid Price Deficiency Notice

Company AnnouncementsSilexion Therapeutics Receives Nasdaq Bid Price Deficiency Notice1M ago8K SLXN

TipRanks NewswireAfter Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)2M agoMRK MRNA

Company AnnouncementsSilexion Therapeutics Receives Nasdaq Delisting Notice, Plans Appeal2M ago8K SLXN

The FlySilexion Therapeutics prices $2.5M public offering at $0.65 per share2M agoSLXN
Company AnnouncementsSilexion Therapeutics Executes Reverse Share Split Amid Strain3M ago8K SLXN
Company AnnouncementsSilexion Therapeutics Closes Public Offering and Strengthens Equity3M ago8K SLXN
TipRanks NewswireImmunotherapy’s Biggest Blind Spot Is a $7 Billion Market. Silexion May Have a Way In (NASDAQ: SLXN)3M agoMRK SLXN

Silexion Updates SIL204 Clinical and Regulatory Roadmap

Company AnnouncementsSilexion Updates SIL204 Clinical and Regulatory Roadmap3M ago8K SLXN

The FlySilexion Therapeutics files to sell ordinary shares, warrants, no amount given3M agoSLXN

Company AnnouncementsSilexion unveils key SIL204 KRAS preclinical findings3M ago8K SLXN